Pittsburgh, PA · Founded 2000 · Privately Held (backing)
Developer of novel biotherapeutic products designed to treat inflamed or damaged tissues. Noveome Biotherapeutics is based in Pittsburgh, PA and was founded in 2000. Its last reported valuation was $200 million in Apr 2019. It has raised $78.7 million across 4 recorded rounds; the latest was a $36.2 million early-stage round in Aug 2023.
Last reported valuation
$200.0M
Oct 2026
Priced at
—
Total raised
$78.7M
Last round
Early Stage VC
Aug 2023
No prints on record
No secondary trades in Noveome Biotherapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Noveome Biotherapeutics with a free account
·Watch Noveome Biotherapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Noveome Biotherapeutics stock.
